Related Experiment Video
Updated: Aug 17, 2026

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
Clinical manifestations of mannan-binding lectin deficiency
S Thiel1, P D Frederiksen, J C Jensenius
1Department of Medical Microbiology and Immunology, University of Aarhus, DK8000 Denmark. st@microbiology.au.dk
Abstract:
Mannan-binding lectin (MBL) is a plasma protein of the innate immune system with the ability to initiate antimicrobial and inflammatory actions. MBL deficiency is common. More than 10% of the general population may, depending on definition, be classified as MBL deficient, underlining the redundancy of the immune system. Ongoing research attempt to illuminate at which conditions MBL deficiency may lead to disease. With examples, this review illustrates the diversity of results obtained so far.
Related Concept Videos
Type I Diabetes III: Clinical Manifestations
Bacterial Meningitis I: Introduction
Bacterial Meningitis
Inflammatory Bowel Disease IV: Clinical Manifestations
Cryptococcal Meningitis
Myasthenia Gravis ll: Pathophysiology
